Monograph
N07AA01 - Neostigmine |
Propably not porphyrinogenic |
PNP |
Rationale
No data pointing to CYP-interaction. References consider it safe.
Chemical description
Cholinesterase inhibitor of short duration used in intestinal and bladder atonia. Hydrolyzed by cholinesterases. No data pointing to CYP-metabolism. Australian list: safe EPI-list: use South African list: use
IPNet drug reports
Uneventful use reported in 1 patient with acute porphyria.
Similar drugs
Tradenames
This list comprises raw data collected from different countries.
In some cases, a more comprehensive list of available drug packages is included.
Consequently, very similar terms may therefore appear multiple times.
Bold names are the searchable terms, while the gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors.
We strive to improve it continuously.
Neostigminemethylsulfaat CF 0,5 mg/ml, injectievloeistof · Prostigmin 0,5 mg/ml, oplossing voor injectie 
NEOSTIGMINA BRAUN 0,5 mg/ml · Prostigmine Ampollas 
Intrastigmina 
MIOSTIN 0,5 mg/ml · NEOSTIGMINA LPH 15 mg · TURKTIPSAN NEOSTIGMINE METHYL SULFATE 0,5 mg/ml 
Neostigmine · Prostigmin 
Neostigmin SAD 
Neostig-carinopharm 
Polstigminum 
Neostigmine-Kalceks 
Neostigmine/Cooper
© NAPOS 2025